RIVOXAN 15 and RIVOXAN 20: Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; Treatment of deep vein thrombosis (DVT) and prevention of recurrent DVT and pulmonary embolism (PE); Treatment of pulmonary embolism (PE) and prevention of recurrent of PE and DVT.